Cyrus Biotechnology logo

Cyrus Biotechnology

Discovering novel biologics using computational structure biology, AI, and massively parallel protein engineering.

17 employees · est. 2014 · Seattle, United States

VS
Profluent logo

Profluent

Grounded in nature, authored by AI

69 employees · est. 2022 · Emeryville, United States

Cyrus Biotechnology is the older company (2014 vs 2022); Profluent is the larger of the two.

Side-by-Side Comparison

Cyrus Biotechnology Profluent
Founded
2014 older 2022
Headquarters
Seattle, United States Emeryville, United States
Employees
17 69 larger
Industry
Biotechnology, Nutrition, Pharmaceutical AI, Biotechnology
Funding Stage
Series B Series Unknown
Total Funding
$45.51M $44.00M
Funding Rounds
8 2
Services
Computational protein design, Therapeutics development, Collaborative discovery programs, Autoimmune disease treatment solutions AI-authored Protein Solutions, CRISPR Gene Editing, Custom Protein Design, Biological Research and Development
Target Customers
Pharmaceutical companies, Biotech researchers, Healthcare providers, Biology-focused academic institutions Pharmaceutical Companies, Agricultural Biotechnology Firms, Industrial Biotech Manufacturers, Research Institutions
Taxonomy
Computational Structural Biology, Protein Engineering, AI In Biotech, Biologics Discovery, Pre-clinical Biotech, Software Tools For Biotech, Protein Design, Molecular Modeling, Rosetta Toolkit, Homology Modeling, Protein Interface Design, Enzyme Interface Design, Biologics Pipeline Development, Pharma Partnerships, Biotech Innovation AI-first Protein Design, Deep Generative Models, Novel Proteins, Biomedicine Revolution, Functional Protein Design, Protein Validation, AI In Biotech, Gene Editing, Machine Learning Applications, Biotech Innovation, Synthetic Biology, Life Sciences, Therapeutic Protein Development, Biomedical Research, Computational Biology
Website
cyrusbio.com profluent.bio
Cyrus Biotechnology logo

About Cyrus Biotechnology

Cyrus Biotechnology, founded in 2014, is a pre-clinical biotech company focused on creating novel biologics using computational structure biology, AI, and protein engineering. Their unique approach addresses serious unmet medical needs through innovative programs across multiple indications. The co...

Profluent logo

About Profluent

Profluent, a pioneering player in the intersection of AI and biotechnology, is making significant strides in revolutionizing protein design. Established in 2022, the company is based in Emeryville, CA, and has garnered support from top-tier investors including Spark Capital, Insight Partners, Air St...

We will tell you when either one moves

BounceWatch watches Cyrus Biotechnology and Profluent for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cyrus Biotechnology and Profluent — by email.

Frequently Asked Questions

Cyrus Biotechnology — Discovering novel biologics using computational structure biology, AI, and massively parallel protein engineering.. Profluent — Grounded in nature, authored by AI. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cyrus Biotechnology has raised $45.51M while Profluent has raised $44.00M.
Cyrus Biotechnology and Profluent operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cyrus Biotechnology with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cyrus Biotechnology on 15 Jun 2026, and Profluent on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy